Eli Lilly & Co. (NYSE: LLY) and Innovent Biologics, Inc. (Innovent) today announced an expansion of their drug development ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Corporate News FDA Management Comments

Piper Jaffray Cuts Price Target on Eli Lilly & Co. (LLY) Following Announced Discontinuation of Evacetrapib October 13, 2015 8:38 AM Lilly and Innovent Biologics Expand Their Strategic Alliance to Include Immuno-Oncology Bispecific Antibodies in China and GloballyOctober 11, 2015 10:00 PM Eli Lilly & Co. (LLY) Acquires Rights to Locemia's Intranasal GlucagoOctober 9, 2015 4:01 PM